{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:49:53Z","timestamp":1788536993007,"version":"build-2803163510"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T00:00:00Z","timestamp":1312934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022486","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T20:48:54Z","timestamp":1313009334000},"page":"e22486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression"],"prefix":"10.1371","volume":"6","author":[{"given":"Sally","family":"Stabler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magaly","family":"Martinez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigmund","family":"Luka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioudmila V.","family":"Loukachevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.","volume":"94","author":"R Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial.","volume":"360","author":"GL Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study.","volume":"360","author":"FH Schroder","year":"2009","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter.","volume":"350","author":"IM Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower.","volume":"294","author":"IM Thompson","year":"2005","journal-title":"Jama"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1158\/1078-0432.CCR-08-1716","article-title":"Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.","volume":"14","author":"DL Blum","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.ju.0000165184.72337.9d","article-title":"Prognostic features in men who died of prostate cancer.","volume":"174","author":"KE Thompson","year":"2005","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.","volume":"457","author":"A Sreekumar","year":"2009","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"22507","DOI":"10.1074\/jbc.R109.019273","article-title":"Glycine N-methyltransferase and regulation of S-adenosylmethionine levels.","volume":"284","author":"Z Luka","year":"2009","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1542\/peds.74.4.509","article-title":"Massachusetts Metabolic Disorders Screening Program: III. Sarcosinemia.","volume":"74","author":"HL Levy","year":"1984","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/0026-0495(93)90198-W","article-title":"Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism.","volume":"42","author":"RH Allen","year":"1993","journal-title":"Metabolism"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0026-0495(93)90010-L","article-title":"Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency.","volume":"42","author":"RH Allen","year":"1993","journal-title":"Metabolism"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI113343","article-title":"Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.","volume":"81","author":"SP Stabler","year":"1988","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/clinchem\/34.11.2357","article-title":"Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates.","volume":"34","author":"DW Horne","year":"1988","journal-title":"Clinical Chemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1289\/ehp.7337","article-title":"Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements.","volume":"113","author":"DB Barr","year":"2005","journal-title":"Environ Health Perspect"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"MJ Pencina","year":"2008","journal-title":"Stat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"P Grambsch","year":"1994","journal-title":"Biometrica"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.nutr.19.1.357","article-title":"Vitamin B12 deficiency in the elderly.","volume":"19","author":"HW Baik","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0022-5347(05)64999-3","article-title":"Serial biopsy results in prostate cancer screening study.","volume":"167","author":"KA Roehl","year":"2002","journal-title":"J Urol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1442-2042.2009.02270.x","article-title":"The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.","volume":"16","author":"U Capitanio","year":"2009","journal-title":"Int J Urol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1200\/JCO.2008.18.3061","article-title":"Sequential testing approach as an efficient and easier alternative for the validation of new predictive technologies in the clinic.","volume":"27","author":"CA Beam","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-291X(75)80297-X","article-title":"Activation of cystathionine synthase by adenosylmethionine and adenosylethionine.","volume":"66","author":"JD Finkelstein","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2010.01.035","article-title":"Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.","volume":"58","author":"F Jentzmik","year":"2010","journal-title":"Eur Urol"},{"key":"ref24","first-page":"e39","article-title":"Letter to the editor.","volume":"58","author":"AK Hewavitharana","year":"2010","journal-title":"Eur Urol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.juro.2010.09.077","article-title":"Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.","volume":"185","author":"F Jentzmik","year":"2011","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1258\/acb.2010.009270","article-title":"Serum sarcosine is not a marker for prostate cancer.","volume":"47","author":"EA Struys","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/pcan.2011.2","article-title":"Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of differentalgorithms of sarcosine in urine.","volume":"14","author":"DL Cao","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.22159","article-title":"Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.","volume":"47","author":"ML Martinez-Chantar","year":"2008","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1158\/0008-5472.CAN-09-3648","article-title":"Plasma homocysteine and cysteine and risk of breast cancer in women.","volume":"70","author":"J Lin","year":"2010","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2009.12.013","article-title":"Lifestyle as risk factor for cancer: Evidence from human studies.","volume":"293","author":"N Khan","year":"2010","journal-title":"Cancer Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ajcn\/88.3.738","article-title":"Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?","volume":"88","author":"AK Elshorbagy","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.urology.2009.12.073","article-title":"Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database.","volume":"76","author":"CJ Kane","year":"2010","journal-title":"Urology"},{"key":"ref33","first-page":"640","article-title":"Alteration of glycine N-methyltransferase activity in fetal, adult, and tumor tissues.","volume":"35","author":"JE Heady","year":"1975","journal-title":"Cancer Research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1078-0432.CCR-06-1551","article-title":"Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.","volume":"13","author":"YC Huang","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:32:52Z","timestamp":1686245572000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022486"}},"subtitle":[],"editor":[{"given":"Natasha","family":"Kyprianou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,10]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022486","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,10]]}}}